Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shakeel Modak

Showing results (21-30 of 137) with videos related to

Pageof 14
Sort By:
Hybridoma and Hybridomics|September 27, 2003
Anti-idiotypic antibody facilitates scFv chimeric immune receptor gene transduction and clonal expansion of human lymphocytes for tumor therapyNai-Kong V Cheung, Hong-Fen Guo, Shakeel Modak, et al.
International Journal of Cancer|December 18, 2023
GM-CSF, G-CSF or no cytokine therapy with anti-GD2 immunotherapy for high-risk neuroblastomaJaume Mora, Shakeel Modak, Joyce Kinsey, et al.
Clinical Nuclear Medicine|February 16, 2026
Early Detection of Neuroblastoma Recurrence on 18F mFBG PETNeeta Pandit-Taskar, Anita Price, Gerald Behr, et al.
Hybridoma and Hybridomics|February 8, 2003
Anti-idiotypic antibody as the surrogate antigen for cloning scFv and its fusion proteinsNai-Kong V Cheung, Hong-Fen Guo, Shakeel Modak, et al.
Pediatric Blood & Cancer|November 3, 2016
Acute myeloid leukemia therapy elicits durable complete response in chemoradio-resistant metastatic paragangliomaSameer Sait, Rachel Kobos, Michael P LaQuaglia, et al.
International Journal of Cancer|July 16, 2025
Rapid COJEC without myeloablative therapy for high-risk neuroblastomaBrian H Kushner, Ellen M Basu, Fiorella Iglesias Cardenas, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2010
High-dose cyclophosphamide-irinotecan-vincristine for primary refractory neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Cancer|June 17, 2006
Ototoxicity from high-dose use of platinum compounds in patients with neuroblastomaBrian H Kushner, Amy Budnick, Kim Kramer, et al.
Leukemia Research|May 3, 2005
Rituximab therapy of lymphoma is enhanced by orally administered (1-->3),(1-->4)-D-beta-glucanShakeel Modak, Guenther Koehne, Andrew Vickers, et al.
Journal of Pediatric Hematology/Oncology|August 18, 2017
Bevacizumab-associated Bowel Microperforation in a Patient With NeuroblastomaRachel Glincher, Anita P Price, Michael P LaQuaglia, et al.
Pageof 14

Showing results (21-30 of 137) with videos related to

Sort By:
Pageof 14
Hybridoma and Hybridomics|September 27, 2003
Anti-idiotypic antibody facilitates scFv chimeric immune receptor gene transduction and clonal expansion of human lymphocytes for tumor therapyNai-Kong V Cheung, Hong-Fen Guo, Shakeel Modak, et al.
International Journal of Cancer|December 18, 2023
GM-CSF, G-CSF or no cytokine therapy with anti-GD2 immunotherapy for high-risk neuroblastomaJaume Mora, Shakeel Modak, Joyce Kinsey, et al.
Clinical Nuclear Medicine|February 16, 2026
Early Detection of Neuroblastoma Recurrence on 18F mFBG PETNeeta Pandit-Taskar, Anita Price, Gerald Behr, et al.
Hybridoma and Hybridomics|February 8, 2003
Anti-idiotypic antibody as the surrogate antigen for cloning scFv and its fusion proteinsNai-Kong V Cheung, Hong-Fen Guo, Shakeel Modak, et al.
Pediatric Blood & Cancer|November 3, 2016
Acute myeloid leukemia therapy elicits durable complete response in chemoradio-resistant metastatic paragangliomaSameer Sait, Rachel Kobos, Michael P LaQuaglia, et al.
International Journal of Cancer|July 16, 2025
Rapid COJEC without myeloablative therapy for high-risk neuroblastomaBrian H Kushner, Ellen M Basu, Fiorella Iglesias Cardenas, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2010
High-dose cyclophosphamide-irinotecan-vincristine for primary refractory neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Cancer|June 17, 2006
Ototoxicity from high-dose use of platinum compounds in patients with neuroblastomaBrian H Kushner, Amy Budnick, Kim Kramer, et al.
Leukemia Research|May 3, 2005
Rituximab therapy of lymphoma is enhanced by orally administered (1-->3),(1-->4)-D-beta-glucanShakeel Modak, Guenther Koehne, Andrew Vickers, et al.
Journal of Pediatric Hematology/Oncology|August 18, 2017
Bevacizumab-associated Bowel Microperforation in a Patient With NeuroblastomaRachel Glincher, Anita P Price, Michael P LaQuaglia, et al.
Pageof 14